Ming-Jen Chen

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Top Venues

ANZ journal of surgery

Journal of breast cancer

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Wei-Sheng Huang, Tao-Yeuan Wang, Chang-Pan Liu, Tun-Pang Chu, Yu-Liang Wang, Ming-Jen Chen
Perianal erythematous skin rash for 2 months. ANZ journal of surgery (2023)
Jiunn-Chang Lin, Chien-Liang Liu, Yuan-Ching Chang, Shih-Ping Cheng, Wen-Chien Huang, Chi-Hsin Lin, Chun-Yi Wu, Ming-Jen Chen
Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib. Investigational new drugs 39 (6) (2021)
Chun-Te Ho, Mei-Hsuan Wu, Ming-Jen Chen, Shih-Pei Lin, Yu-Ting Yen, Shih-Chieh Hung
Combination of Mesenchymal Stem Cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer Therapy. Biomedicines 9 (5) (2021)
Chien-Liang Liu, Ming-Jen Chen, Jiunn-Chang Lin, Chi-Hsin Lin, Wen-Chien Huang, Shih-Ping Cheng, Shan-Na Chen, Yuan-Ching Chang
Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway. Journal of breast cancer 22 (2) (2019)